Our HypoSense® checks your product even more intensively. Of course, an ingredient check is also carried out here first. This is followed by both an epicutaneous test and a Safety-in-Use test on 30 test subjects with sensitive skin. In addition, of these 30 test persons, 30% have neurodermatitis, 30% are allergic and 20% are asthmatic (only for Safety-in-Use testing). Another major advantage is that you can define and add more detailed inclusion criteria and efficacy analyses for the Safety-in-Use study. The Safety-in-Use study takes place for at least 4 weeks and a final epicutaneous test is included to additionally check the sensitization potential.

Combining high-value methods
Creating safe and effective "Hypoallergenic" products is a top priority for the cosmetics industry. We’re committed to meeting consumer needs while ensuring product safety. Traditionally, this claim relies on HRIPT testing, which has raised ethical concerns and lacks precise protocols. We’re exploring scientifically-backed alternatives to enhance product safety claims. Our goal is to provide clearer information to consumers, making "Hypoallergenic" labeling more transparent and consumer-friendly.